Viatris Inc recalls Levsin injection (hyoscyamine sulfate injection, USP), 0.5 mg per ml in water for Injection, 1 ml Ampule (Box of 5 ampules), Rx Only,…

CGMP Deviations: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.

Date

2023-06-14

Country

United States

Brand

Viatris

Product

Levsin injection (hyoscyamine sulfate injection, USP), 0.5 mg per ml in water for Injection, 1 ml Ampule (Box of 5 ampules), Rx Only,…

Classification

Class II

Units

Product was distributed to 10 distributors who may have further distribute the…

Category

Drugs & medical

Source

FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

1. Check the product name, strength and lot number against the official notice.
2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Viatris recalls

1. 2024-12-18
2. US
   Drugs & medicalClass II

   Viatris Inc recalls Levothyroxine Sodium Tablets USP, 150 mcg, packaged in a) 90-count bottles (NDC 0378-1815-77) and b) 1000-count bottles (NDC…

   Superpotent Drug and Subpotent Drug: potency failures obtained

   FDA · DrugViatris IncNationwide within the United States and Puerto RicoOfficial notice →
3. 2024-07-24
4. US
   Drugs & medicalClass II

   Viatris Inc recalls Cardura XL (doxazosin) extended release tablets 8mg, 30-count bottles, Rx Only Made in Singapore, Distributed by Roerig Division of Pfizer…

   Failed Impurities/Degradation Specifications

   FDA · DrugViatris IncU.S. NationwideOfficial notice →
5. 2024-05-08
6. US
   Drugs & medicalClass III

   Viatris Inc recalls Valacyclovir Tablets USP, 500 mg, 90 count bottles, Rx Only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 USA, NDC…

   Failed Tablet/Capsule Specifications: There is a potential for the imprint, M 122, to be missing on some tablets.

   FDA · DrugViatris IncNationwide within the united statesOfficial notice →
7. 2022-11-23
8. US
   Drugs & medicalClass II

   Viatris Inc recalls Carvedilol Tablets, USP, 25 mg, 500-count bottles, Rx Only, Mfg: Mylan Pharmaceuticals Inc. Morgantown, WV 36505, Made in India, NDC…

   Failed Tablet/Capsule Specifications: Tablets exceeds specification for weight and thickness.

   FDA · DrugViatris IncNationwide in the USAOfficial notice →
9. 2022-11-16
10. US
    Drugs & medicalClass I

    Viatris Inc recalls Octreotide Acetate Injection 500 mcg/mL, 10 x 1 mL Single-Dose Unit-of-Use Syringes, For Subcutaneous or Intravenous Use, Rx Only,…

    Presence of Particulate Matter: Product complaint for the presence of glass particles in a syringe.

    FDA · DrugViatris IncNationwide in the USAOfficial notice →
11. 2022-10-05
12. US
    Drugs & medicalClass II

    Viatris Inc recalls Ampicillin for Injection, USP, 2 grams/vial NDC 67457-352-02, packaged in 10 x 2 g vials per carton NDC 67457-352-10, Rx only, Mylan…

    Presence of Particulate Matter: A complaint was received for the presence of a single strand of hair in one vial.

    FDA · DrugViatris IncNationwide in the USAOfficial notice →

Other drugs & medical recalls in the United States

1. 2023-06-14
2. US
   Drugs & medicalClass III

   HF Acquisition Co LLC recalls GLYCOPYRROLATE INJECTION, USP 0.2MG/ML, 1mL VIAL, manufactured by HF Acquisition Co. LLC, Mukilteo, WA 98275, NDC 51662-1487-3

   Labeling: Label Mix-up

   FDA · DrugHF Acquisition Co LLCDistributed in TX, AZ and CA onlyOfficial notice →
3. US
   Drugs & medicalClass II

   SUN PHARMACEUTICAL INDUSTRIES INC recalls Buprenorphine Sublingual Tablets, 8 mg, 30 count-bottles, Rx only, Manufactured by: Sun Pharma, NDC 62756-460-83.

   CGMP Deviations

   FDA · DrugSUN PHARMACEUTICAL INDUSTRIES INCProduct was distributed to 19 distributors nationwide.Official notice →
4. US
   Drugs & medicalClass II

   Golden State Medical Supply Inc. recalls Travoprost Ophthalmic Solution, USP (Ionic Buffered Solution), 0.004%, Rx only, Manufactured by Apotex Inc., Manufactured by:…

   Lack of Assurance of Sterility: Tamper Evidence Seal is missing on secondary container.

   FDA · DrugGolden State Medical Supply Inc.Nationwide in the USAOfficial notice →
5. US
   Drugs & medicalClass II

   Empower Clinic Services LLC dba Empower Pharmacy recalls ASCORBIC ACID PRESERVED INJECTION SOLUTION, 500 mg/mL, 30 mL Sterile Multiple-Dose Vial, RX ONLY, Compounded…

   Mislabeling: preservative free product labeled as preserved.

   FDA · DrugEmpower Clinic Services LLC dba Empower PharmacyDistributed Nationwide in the USAOfficial notice →
6. 2023-06-07
7. US
   Drugs & medicalClass II

   Linkbio Corp. recalls LINK SymphoKnee System L-Shaped Femoral Augment, Medial-Right/Lateral-Left, Sz 5-6 Tilastan, cemented. Intended for primary and revision…

   Contains the incorrect implant in the packaging. The packaging incorrectly contains the opposite side of the implant (Lateral-Right/Medial-Left instead of Medial-Right/Lateral-Left).

   FDA · DeviceLinkbio Corp.US Nationwide Distribution - AL, GA, IL, IN, LA, NV, TXOfficial notice →
8. US
   Drugs & medicalClass II

   Smith & Nephew, Inc. recalls Smith&Nephew ENGAGE Cementless Partial Knee System, Tibial Anchor Stem, Part Numbers: a) REF 1-10011-100 (SIZE 1-2), b) REF 1-10011-200…

   Recent complaint data indicates that the revision rate may be trending higher than corresponding similar devices in global joint replacement registries. The data identifies a potential signal that the performance is an…

   FDA · DeviceSmith & Nephew, Inc.US Nationwide distribution.Official notice →